Suzetrigine-enhanced multimodal opioid-sparing therapy

Suzetrigine · Icahn School of Medicine at Mount Sinai

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Suzetrigine-enhanced multimodal opioid-sparing therapy, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery [Phase 3]

See pricing